Back
Viking Therapeutics Quote, Financials, Valuation and Earnings
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
80
VKTX
Viking Therapeutics
Last Price:
68.17
Seasonality Move:
18.2%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pmViking Therapeutics Price Quote
$68.17
+3.71 (+5.76%)
(Updated: September 19, 2024 at 6:55 PM ET)
Viking Therapeutics Key Stats
Buy
80
Viking Therapeutics (VKTX)
is a Buy
Day range:
$62.62 - $66.05
52-week range:
$8.28 - $99.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
7.75%
Volume:
2.1M
Avg. volume:
3.2M
1-year change:
366.59%
Market cap:
$7.1B
Revenue:
$0
EPS:
$-0.94
How Much Does Viking Therapeutics Make?
Data Unavailable
Is Viking Therapeutics Growing As A Company?
Data Unavailable
Viking Therapeutics Stock Price Performance
-
Did Viking Therapeutics Stock Go Up Last Month?
Viking Therapeutics share price went up by 13.67% last month -
Did VKTX's Share Price Rise Over The Last Year?
VKTX share price rose by 366.59% over the past 1 year
What Is Viking Therapeutics 52-Week High & Low?
-
What Is Viking Therapeutics’s 52-Week High Share Price?
Viking Therapeutics has traded as high as $99.41 over the past 52 weeks -
What Is Viking Therapeutics’s 52-Week Low Share Price?
Viking Therapeutics has traded as low as $8.28 over the past 52 weeks
Viking Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Viking Therapeutics?
-
How Much Debt Does Viking Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Viking Therapeutics Have?
Cash and short term investments quarterly total is $942.3M -
What Is Viking Therapeutics’s Book Value Per Share?
Book value per share is 8.31
Is Viking Therapeutics Cash Flow Positive?
-
What Is VKTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$71.9M -
What Is Viking Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $609.1M -
What Is Viking Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$562.7M
Viking Therapeutics Return On Invested Capital
Data Unavailable
Viking Therapeutics Earnings Date & Stock Price
-
What Is Viking Therapeutics's Stock Price Today?
A single share of VKTX can be purchased today for 64.46 -
What Is Viking Therapeutics’s Stock Symbol?
Viking Therapeutics trades on the nasdaq under the ticker symbol: VKTX -
When Is Viking Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Viking Therapeutics is scheduled on October 25, 2024 -
When Is VKTX's next ex-dividend date?
Viking Therapeutics's next ex-dividend date is September 20, 2024 -
How To Buy Viking Therapeutics Stock?
You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Viking Therapeutics Competitors
-
Who Are Viking Therapeutics's Competitors?
Below is a list of companies who compete with Viking Therapeutics or are related in some way:
Viking Therapeutics Dividend Yield
-
What Is VKTX Dividend Yield?
Viking Therapeutics’s dividend yield currently is 0% -
What Is Viking Therapeutics’s Payout Ratio?
Viking Therapeutics’s payout ratio is 0% -
When Did Viking Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Viking Therapeutics’s Dividend Per Share?
Viking Therapeutics pays a dividend of $0.00 per share
Viking Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 25% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 109.70 |
| Upside from Last Price: | 70.18% |